Target intelligence / Profile preview

Acetylcholine release at peripheral cholinergic nerve terminals

Molecular classification
Other (neurotransmitter release process)
01

Overview

Acetylcholine release at peripheral cholinergic nerve terminals refers to the process in which acetylcholine, a major neurotransmitter in both the central and peripheral nervous systems, is exocytosed from nerve endings into the synaptic cleft, particularly at sites such as neuromuscular junctions and autonomic ganglia. Release is triggered by presynaptic depolarization and calcium influx, facilitating vesicle fusion with the presynaptic membrane via the SNARE complex and VAChT, allowing acetylcholine to act rapidly on postsynaptic nicotinic or muscarinic receptors. Disruption of this process leads to profound neuromuscular or autonomic dysfunction, and it is a point of action for certain neurotoxins (e.g., botulinum toxin) and clinical disorders (e.g., myasthenia gravis).

Other names
Acetylcholine exocytosisAcetylcholine secretionCholinergic neurotransmitter releaseSynaptic acetylcholine release
02

Mechanism of action

Inhibition of vesicle fusion (e.g., botulinum toxin inhibits SNARE proteins), stimulation of vesicle release (e.g., black widow spider venom causes excessive release), and modulation of presynaptic calcium influx (e.g., Mg2+, specific disease states).

03

Biological functions

Neurotransmitter releaseNeuromuscular signalingAutonomic nervous system transmission
04

Disease associations

Neuromuscular disorders (e.g., myasthenia gravis, botulism)Autonomic dysfunctionOther (potential involvement in some neurodegenerative and autoimmune conditions)
05

Safety considerations

Systemic inhibition (e.g., botulinum toxin) can cause paralysis and loss of autonomic functionsExcessive release (e.g., black widow spider venom) can cause muscle spasms, autonomic crisisRisk of respiratory arrest in severe disruption
06

Interacting drugs

Botulinum toxin

4 more in the full profile.

07

Biomarkers

Decreased evoked muscle responseAcetylcholine levels in synaptic cleft

Beyond the preview

Go deeper on Acetylcholine release at peripheral cholinergic nerve terminals.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetylcholine release at peripheral cholinergic nerve terminals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call